Cargando…

Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients

DNMT3A mutation is known as a recurrent event in acute myelogenous leukemia (AML) patients. However, association between DNMT3A genetic polymorphisms and AML patients' outcomes is unknown. DNMT3A 11 SNPs (rs11695471, rs2289195, rs734693, rs2276598, rs1465825, rs7590760, rs13401241, rs7581217, r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Xiao-Qing, Zhang, Dao-Yu, Yan, Han, Yang, Yong-Long, Zhu, Ke-Wei, Chen, Yan-Hong, Li, Xi, Yin, Ji-Ye, Li, Xiao-Lin, Zeng, Hui, Chen, Xiao-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312402/ https://www.ncbi.nlm.nih.gov/pubmed/27528035 http://dx.doi.org/10.18632/oncotarget.11143

Ejemplares similares

Influence of DNMT3A R882 mutations on AML prognosis determined by the allele ratio in Chinese patients
por: Yuan, Xiao-Qing, et al.
Publicado: (2019)

DNMT3A R882 Mutations Predict a Poor Prognosis in AML: A Meta-Analysis From 4474 Patients
por: Yuan, Xiao-Qing, et al.
Publicado: (2016)

Association of genetic polymorphisms in genes involved in Ara-C and dNTP metabolism pathway with chemosensitivity and prognosis of adult acute myeloid leukemia (AML)
por: Zhu, Ke-Wei, et al.
Publicado: (2018)

Clinical Features and MicroRNA Expression Patterns Between AML Patients With DNMT3A R882 and Frameshift Mutations
por: Yang, Li, et al.
Publicado: (2019)

CD44v6 chimeric antigen receptor T cell specificity towards AML with FLT3 or DNMT3A mutations
por: Tang, Ling, et al.
Publicado: (2022)

DNMT3A(R882)-associated hypomethylation patterns are maintained in primary AML xenografts, but not in the DNMT3A(R882C) OCI-AML3 leukemia cell line
por: Chen, David, et al.
Publicado: (2018)

Graphdiyne oxide nanosheets display selective anti-leukemia efficacy against DNMT3A-mutant AML cells
por: Wang, Qiwei, et al.
Publicado: (2022)

Leukemia cutis with IDH1, DNMT3A and NRAS mutations conferring resistance to venetoclax plus 5-azacytidine in refractory AML
por: Wang, JingHan, et al.
Publicado: (2020)

P564: HOMOHARRINGTONINE AND CYTARABINE COMBINED WITH VENETOCLAX (HAV) FOR ADULT PATIENTS WITH DE NOVO AML
por: Luo, Xiao-Hua, et al.
Publicado: (2023)

DNMT1, DNMT3A and DNMT3B Polymorphisms Associated With Gastric Cancer Risk: A Systematic Review and Meta-analysis
por: Li, Hongjia, et al.
Publicado: (2016)

Identification of DNMT3B2 as the Predominant Isoform of DNMT3B in Porcine Alveolar Macrophages and Its Involvement in LPS-Stimulated TNF-α Expression
por: Zhang, Yanbing, et al.
Publicado: (2020)

RNAi-Mediated Screen of Primary AML Cells Nominates MDM4 as a Therapeutic Target in NK-AML with DNMT3A Mutations
por: Sidorova, Olga Alexandra, et al.
Publicado: (2022)

Genetic Effects of Polymorphisms in Myogenic Regulatory Factors on Chicken Muscle Fiber Traits
por: Yang, Zhi-Qin, et al.
Publicado: (2015)

Gene-wide significant association analyses of DNMT1 genetic variants with Parkinson’s disease
por: Wang, Jian-Yong, et al.
Publicado: (2023)

DNMT3A mutation leads to leukemic extramedullary infiltration mediated by TWIST1
por: Xu, Jie, et al.
Publicado: (2016)

Cranial irradiation inhibits hippocampal neurogenesis via DNMT1 and DNMT3A
por: Ji, Shengjun, et al.
Publicado: (2018)

A Meta-Analysis of the Association between DNMT1 Polymorphisms and Cancer Risk
por: Li, Hao, et al.
Publicado: (2017)

A Genetic Polymorphism in RBP4 Is Associated with Coronary Artery Disease
por: Wan, Ke, et al.
Publicado: (2014)

DNMT inhibitors reverse a specific signature of aberrant promoter DNA methylation and associated gene silencing in AML
por: Lund, Kirstin, et al.
Publicado: (2014)

DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation
por: Jawad, Majd, et al.
Publicado: (2022)

CBFB-MYH11 Fusion Sequesters RUNX1 in Cytoplasm to Prevent DNMT3A Recruitment to Target Genes in AML
por: Liu, Peng, et al.
Publicado: (2021)

DNMT1-maintained hypermethylation of Krüppel-like factor 5 involves in the progression of clear cell renal cell carcinoma
por: Fu, Rong-Jie, et al.
Publicado: (2017)

Expression of DNMT1 and DNMT3a Are Regulated by GLI1 in Human Pancreatic Cancer
por: He, ShanShan, et al.
Publicado: (2011)

A Histone Acetyltransferase p300 Inhibitor C646 Induces Cell Cycle Arrest and Apoptosis Selectively in AML1-ETO-Positive AML Cells
por: Gao, Xiao-ning, et al.
Publicado: (2013)

CRISPR/Cas9‐mediated gene knockout for DNA methyltransferase Dnmt3a in CHO cells displays enhanced transgenic expression and long‐term stability
por: Jia, Yan‐Long, et al.
Publicado: (2018)

DNMT1 genetic polymorphisms affect breast cancer risk in the central European Caucasian population
por: Kullmann, Kathrin, et al.
Publicado: (2013)

Suppressing microRNA-29c promotes biliary atresia-related fibrosis by targeting DNMT3A and DNMT3B
por: Wang, Jian-yao, et al.
Publicado: (2019)

The combination of NPM1, DNMT3A, and IDH1/2 mutations leads to inferior overall survival in AML
por: Dunlap, Jennifer B., et al.
Publicado: (2019)

Comparison of High-Resolution Melting (HRM) Analysis with Direct Sequencing for the Detection of DNMT3A Mutations in AML Patients
por: Moonesi, Mohammadreza, et al.
Publicado: (2022)

P456: LEUKEMOGENESIS BY AML-SPECIFIC DRIVER MUTATIONS WITHIN DNMT3A, IDH2 AND NPM1
por: Mehmetbeyoglu, Ecmel, et al.
Publicado: (2023)

Basigin rs8259 Polymorphism Confers Decreased Risk of Chronic Heart Failure in a Chinese Population
por: Li, Mu-Peng, et al.
Publicado: (2017)

Inhibiting CCN1 blocks AML cell growth by disrupting the MEK/ERK pathway
por: Niu, Chang-Chun, et al.
Publicado: (2014)

Ethanol-triggered Lipophagy Requires SQSTM1 in AML12 Hepatic Cells
por: Wang, Lin, et al.
Publicado: (2017)

LncSIK1 enhanced the sensitivity of AML cells to retinoic acid by the E2F1/autophagy pathway
por: Wang, Ke, et al.
Publicado: (2022)

A Predictor Combining Clinical and Genetic Factors for AML1-ETO Leukemia Patients
por: Yang, Min, et al.
Publicado: (2022)

Associations of DNMT3B −149C>T and −2437T>A polymorphisms and lung cancer risk in Chinese population
por: Gao, Min, et al.
Publicado: (2016)

Tumor suppressor CEBPA interacts with and inhibits DNMT3A activity
por: Chen, Xiufei, et al.
Publicado: (2022)

MiRNAs and miRNA Polymorphisms Modify Drug Response
por: Li, Mu-Peng, et al.
Publicado: (2016)

The Impact of DNMT3A Status on NPM1 MRD Predictive Value and Survival in Elderly AML Patients Treated Intensively
por: Heiblig, Maël, et al.
Publicado: (2021)

Genetic polymorphisms of GZMB and vitiligo: A genetic association study based on Chinese Han population
por: Xu, Meifeng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q37mqdoske9o4ktj7m44ro941c